
    
      IND Number: 79,599/101,943

      Primary Purpose: Other - Phase 1 Clinical Pharmacology study to determine the effect of renal
      impairment on the exposure of DCV, ASV, BMS-791325 (fixed dosed combination) and BMS-791325
      given in multiple doses

      Fixed dose combination (FDC)

      Fixed Dose Combination of Daclatasvir, Asunaprevir and BMS-791325 (DCV 3DAA FDC)
    
  